Position in ZTS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$215,148
-$881,013 QoQ
Shares Held
2,994
-67.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,033
of 1,412 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $6,951,552 across 44 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
143,876 | $4,874,518 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,544 | $836,585 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
3,008 | $506,968 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
2,994 | $215,148 | |
| 5 | LQDA |
Liquidia Corp
|
950 | $75,743 | |
| 6 | CTOR |
Citius Oncology, Inc.
|
107,424 | $69,825 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
447 | $49,590 | |
| 8 | VTRS |
Viatris Inc
|
2,398 | $38,080 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $215,148 | 2,994 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,096,161 | 9,273 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,153,391 | 9,167 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,402,330 | 9,584 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $1,539,850 | 9,874 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $1,637,608 | 9,946 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,634,676 | 10,033 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,733,997 | 8,875 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $1,581,736 | 9,124 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,329,652 | 7,858 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $1,515,209 | 7,677 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $1,304,502 | 7,498 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $3,464,348 | 20,117 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $6,234,675 | 37,459 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $3,565 | 41,248 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $5,243,979 | 35,363 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,062 | 12 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,801,028 | 30,760 | Shares | Sole | 2022-08-08 | |
| 2021-12-31 | $6,904,584 | 28,294 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $5,530,660 | 28,488 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $5,183,603 | 27,815 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $4,255,739 | 27,024 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $3,699,587 | 22,354 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $3,379,997 | 20,439 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $2,724,081 | 19,878 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,005,908 | 17,044 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||